Best Treatments for Menopause Hair Thinning: 5 Options Ranked
What are the best treatments for Menopause Hair Thinning, and which one fits me?
Reviewed by Taylor Anderson, RN
Aesthetic Registered Nurse
Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.
Updated October 2, 2026
Quick answer
Topical minoxidil is the best-proven treatment for menopause hair thinning. It is FDA-approved for women and roughly doubled the odds of visible regrowth across trials. Low-dose oral minoxidil, spironolactone, laser caps and PRP are the next options, with smaller studies, while finasteride failed in postmenopausal women and hormone therapy is not a hair treatment.
In this guide
Key takeaways
- A Cochrane review of 47 trials found women using minoxidil were nearly twice as likely to report moderate to marked regrowth as those on placebo.
- Oral minoxidil 1 mg improved hair thickness about as much as 5% topical solution in a six-month randomized trial.
- Spironolactone helped about 57% of women in pooled studies, more often when combined with minoxidil, though most data are observational.
- Finasteride 1 mg did not improve hair counts in a one-year trial of postmenopausal women.
- Expect six to 12 months before judging any treatment, and extra shedding in the first weeks of minoxidil.
Minoxidil is the best-proven treatment for thinning hair in and after menopause. It is FDA-approved for women in 2% and 5% strengths, and in a review of 47 trials it roughly doubled the odds of visible regrowth (Cochrane review 2016). Low-dose oral minoxidil, spironolactone, laser caps and PRP come next, with smaller studies. Finasteride did not help postmenopausal women in a year-long trial, and hormone therapy is not a hair-loss treatment.
How we chose
We ranked each option on four things, checked on September 30, 2026:
- Results in randomized trials of women with female pattern hair loss, the slow thinning at the part and crown that becomes more common after menopause.
- Number and quality of studies. A Cochrane review, which grades trials for bias, counts for more than a single small study.
- FDA status for women's hair loss.
- Side effects and practical hassle, such as daily use or clinic visits.
First, rule out the fixable causes. Thinning that looks like pattern loss can come from low iron or other conditions, which is why dermatologists check before starting treatment (AAD). The research on iron is mixed. Some studies link low iron to thinning in women and others do not, and after menopause low iron needs its own workup to find the cause (Trost 2006, JAAD).
1. Topical minoxidil (2% or 5%)
Minoxidil is an over-the-counter liquid or foam you apply to the scalp. It extends the growth phase of each hair and thickens fine strands. The FDA has approved 2% and 5% products for women, and it is the most-recommended treatment for this kind of hair loss (AAD).
A Cochrane review of 47 trials found women on minoxidil were nearly twice as likely as those on placebo to report moderate to marked regrowth, with about 13 more hairs per square centimeter on average. It found no clear difference between 2% and 5% (Cochrane review 2016). In a 48-week trial of 381 women, 5% beat placebo on hair counts and on both patient and doctor ratings, and women rated it higher than 2% (Lucky 2004, JAAD).
Best for: almost everyone starting out, since it is cheap, proven and needs no prescription.
Trade-offs: expect extra shedding in the first two to eight weeks, and six to 12 months before you can judge results. Scalp itch and stray facial hair can happen. Results fade if you stop (AAD).
2. Low-dose oral minoxidil
This is the same drug in a tiny daily pill, prescribed off-label (outside its official approved use) for hair. Many women find it easier than a twice-daily scalp application.
In a six-month randomized trial of 65 people, 1 mg of oral minoxidil improved hair thickness about as much as 5% topical solution. Topical scored slightly better on photo density, but the difference between groups was not significant, and more than 60% in each group were satisfied (Asilian 2024). Our oral vs topical minoxidil guide covers dosing and side effects in detail.
Best for: women who hate the daily scalp routine or had irritation from topical minoxidil.
Trade-offs: needs a prescription and a check of blood pressure and heart history. Unwanted facial and body hair is more common than with the topical form. The trial was small and included men.
3. Spironolactone
Spironolactone is a decades-old blood pressure pill that blocks androgens, the hormones that shrink hair follicles in pattern hair loss. Dermatologists prescribe it off-label for women's thinning.
A 2023 review pooling trials and observational studies found 57% of women improved overall, rising to 66% when spironolactone was combined with another treatment such as minoxidil, versus 43% when used alone. Results varied widely between studies (Aleissa 2023, Cureus). The Cochrane reviewers flagged spironolactone as widely used but still lacking good randomized trials (Cochrane review 2016).
Best for: women whose thinning comes with signs of excess androgens, such as chin hair or adult acne, often as an add-on to minoxidil.
Trade-offs: mostly observational evidence. It needs a prescription and periodic blood tests for potassium, and it can cause menstrual changes in women who still have periods.
4. Low-level laser therapy (caps, helmets, combs)
These home devices shine red light on the scalp. Several are FDA-cleared as medical devices for pattern hair loss.
A meta-analysis of seven double-blind randomized trials of FDA-cleared home devices found a significant increase in hair density versus sham devices, in both women and men, with both caps and combs (Lueangarun 2021). The Cochrane review found hair counts rose with laser combs, but women did not rate them better than sham devices (Cochrane review 2016).
Best for: women who want a drug-free add-on and can commit to regular sessions.
Trade-offs: devices cost hundreds of dollars, quality varies, and many on the market have no published trials.
5. Platelet-rich plasma (PRP)
PRP means drawing your blood, concentrating the platelets and injecting them into the scalp.
In a small trial of 30 women, scalp areas injected with PRP four times showed greater hair density and thickness than areas injected with saline, and results held six months later (Tawfik 2018). Methods differ a lot from clinic to clinic, and most studies are small.
Best for: women who want an in-office option to add to minoxidil.
Trade-offs: several injection sessions, paid out of pocket, and no standard method.
Skip or reconsider
- Finasteride for postmenopausal women. In a one-year trial of 137 postmenopausal women aged 41 to 60, finasteride 1 mg did not increase hair counts or slow thinning compared with placebo (Price 2000, JAAD).
- Hormone therapy as a hair treatment. A 2026 dermatology review concluded hormone therapy is not indicated for hair loss alone. Women who already use it for symptoms can usually continue transdermal estrogen without added hair concerns (Lee 2026, Dermatology). Read more in our hormone therapy guide.
Comparison at a glance
| Option | Best for | Evidence weight | Main trade-off | Access |
|---|---|---|---|---|
| Topical minoxidil | First treatment for most women | FDA-approved for women, Cochrane-reviewed | Early shedding, daily use | Over the counter |
| Oral minoxidil | Skipping the scalp routine | Small randomized trials | Facial hair, blood pressure check | Prescription, off-label |
| Spironolactone | Thinning with acne or chin hair | Mostly observational | Blood tests, cycle changes | Prescription, off-label |
| Laser caps and combs | Drug-free add-on | Meta-analysis of sham-controlled trials | Device cost, mixed patient ratings | FDA-cleared devices |
| PRP | In-office add-on | Small randomized trials | Repeat injections, no standard method | Clinic |
How to choose
Start with topical minoxidil once other causes have been ruled out. Give it six to 12 months. If the daily routine is the problem, ask about oral minoxidil. If you also have acne or chin hair, spironolactone is the common add-on. Laser caps and PRP are extras, not replacements.
Copper peptides are another option some women add. See our look at GHK-Cu with minoxidil. To get a hair plan matched to your goals and health history, take the HOD quiz.
Ready to make a move?
Answer three questions to see the options, prices, and providers that fit your goals.
See My PlanFAQ
Why does my hair get thinner after menopause?
The most common cause is female pattern hair loss, which is inherited and becomes more common after menopause, likely because hormones shift. The part widens and hair near the temples can recede. Other causes can look similar, which is why a dermatologist checks before treating.
Will hormone therapy stop menopausal hair loss?
Not on its own. A 2026 dermatology review found hormone therapy is not indicated for hair loss alone. Women who use it for hot flashes or other symptoms can usually continue transdermal estrogen without added hair concerns.
Is 5% minoxidil better than 2% for women?
In one 48-week trial, women rated 5% higher than 2%, and 5% beat placebo on every main measure. A Cochrane review pooling several trials found no clear difference between the strengths. The 5% foam is used once daily, which many women find easier.
How long does minoxidil take to work for women?
Plan on six to 12 months of daily use before judging results. Many women shed more in the first two to eight weeks, which stops as new growth starts. If you stop using it, the benefit fades.
Does finasteride work for women after menopause?
A one-year randomized trial of 137 postmenopausal women found finasteride 1 mg did not increase hair growth or slow thinning compared with placebo. Some dermatologists use other doses or related drugs, but the trial evidence for finasteride at this dose is negative.
Keep reading
Sources (10)
- Interventions for female pattern hair loss (Cochrane review) · Cochrane Database of Systematic Reviews (PubMed) · captured September 30, 2026
- Thinning hair and hair loss: Could it be female pattern hair loss? · American Academy of Dermatology · captured September 30, 2026
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss · Journal of the American Academy of Dermatology (PubMed) · captured September 30, 2026
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss · Journal of the American Academy of Dermatology (PubMed) · captured September 30, 2026
- Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: a randomized controlled trial · Journal of Cosmetic Dermatology (PubMed) · captured September 30, 2026
- The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis · Cureus (PubMed) · captured September 30, 2026
- A Systematic Review and Meta-analysis of Randomized Controlled Trials of FDA-Approved, Home-use, Low-Level Light Therapy Devices for Pattern Hair Loss · Journal of Clinical and Aesthetic Dermatology (PubMed) · captured September 30, 2026
- The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study · Journal of Cosmetic Dermatology (PubMed) · captured September 30, 2026
- Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia · Journal of the American Academy of Dermatology (PubMed) · captured September 30, 2026
- Hormone Replacement Therapy and Hair: A Review for Trichologists Treating Menopausal Women · Dermatology (PubMed) · captured September 30, 2026